Hospitalized patients with HIV and COVID‑19 receiving convalescent plasma: A case series

Silvera,Richard J.; Lin,Hung-Mo; Rahman,Farah; Arvind,Varun; Chang,Helena L.; Baine,Ian; Arinsburg,Suzanne A.; Bouvier,Nicole M.; Aberg,Judith A.; Liu,Sean T.H.

doi:10.3892/wasj.2022.160

Hospitalized patients with HIV and COVID‑19 receiving convalescent plasma: A case series

Authors:
- Richard J. Silvera
- Hung-Mo Lin
- Farah Rahman
- Varun Arvind
- Helena L. Chang
- Ian Baine
- Suzanne A. Arinsburg
- Nicole M. Bouvier
- Judith A. Aberg
- Sean T.H. Liu
View Affiliations

Affiliations: Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA, Department of Pathology, Molecular and Cell‑Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Published online on: April 26, 2022 https://doi.org/10.3892/wasj.2022.160
Article Number: 25
Copyright: © Silvera et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The use of convalescent plasma in coronavirus disease 2019 (COVID‑19) in the general population has not been shown to have a clear benefit. However, there are limited data available on its use in specific populations, such as in persons with human immunodeficiency virus (HIV; PWH). The present case series study describes 12 hospitalized PWH who received convalescent plasma for severe COVID‑19 between March 2020 and July 2020. Demographics, pre‑existing comorbidities, HIV status, and COVID‑19 management were reported and examined in a multivariate analysis. A high mortality rate of 58%, (7 out of 12 PWH) was observed in those receiving the convalescent plasma. By contrast, a brief review of 13 previously published cohorts of PWH hospitalized with COVID‑19 revealed a cumulative mortality of 19% (85 of 439 PWH). In the present case series study, PWH had a significantly higher relative risk for in‑hospital COVID‑19‑associated mortality compared with individuals without HIV (unadjusted range, 2.10‑2.52; and adjusted range, 1.79‑2.08; P<0.02 in all analyses). Covariate‑adjustments were made for patient demographics, pre‑existing co‑morbidities, and mechanical ventilation needs. The high mortality rate of the present case series may be related to random sampling or an adverse effect of convalescent plasma in PWH and severe COVID‑19. Additional research is thus required to investigate the risks and benefits of the use of COVID‑19 convalescent plasma in PWH.

View Figures

View References

1	RECOVERY Collaborative Group. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): A randomised controlled, open-label, platform trial. Lancet. 397:2049–2059. 2021.PubMed/NCBI View Article : Google Scholar
2	Bégin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chassé M, Devine DV, et al: Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicentre, randomized, open-label trial. Trials. 22(323)2021.PubMed/NCBI View Article : Google Scholar
3	Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M, Broglio K, Brunkhorst F, et al: The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design. Ann Am Thorac Soc. 17:879–891. 2020.PubMed/NCBI View Article : Google Scholar
4	Gudipati S, Brar I, Murray S, McKinnon JE, Yared N and Markowitz N: Descriptive analysis of patients living with HIV affected by COVID-19. J Acquir Immune Defic Syndr. 85:123–126. 2020.PubMed/NCBI View Article : Google Scholar
5	Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, Reich J, Jones S and Rahimian J: Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 85:6–10. 2020.PubMed/NCBI View Article : Google Scholar
6	Nagarakanti SR, Okoh AK, Grinberg S and Bishburg E: Clinical outcomes of patients with COVID-19 and HIV coinfection. J Med Virol. 93:1687–1693. 2021.PubMed/NCBI View Article : Google Scholar
7	Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J and Sobieszczyk ME: Clinical characteristics and outcomes in people living with Human Immunodeficiency Virus hospitalized for COVID-19. Clin Infect Dis. 71:2294–2297. 2020.PubMed/NCBI View Article : Google Scholar
8	Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, De Freitas JK, Miotto R, Zhao S, Polak P, et al: COVID-19 and people with HIV infection: Outcomes for hospitalized patients in New York City. Clin Infect Dis. 71:2933–2938. 2020.PubMed/NCBI View Article : Google Scholar
9	Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ, Inglesby P, et al: HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 8:e24–e32. 2021.PubMed/NCBI View Article : Google Scholar
10	Calza L, Bon I, Tadolini M, Borderi M, Colangeli V, Badia L, Verucchi G, Rossini G, Vocale C, Gaibani P, et al: COVID-19 in patients with HIV-1 infection: A single-centre experience in northern Italy. Infection. 49:333–337. 2021.PubMed/NCBI View Article : Google Scholar
11	Childs K, Post FA, Norcross C, Ottaway Z, Hamlyn E, Quinn K, Juniper T and Taylor C: Hospitalized patients with COVID-19 and human immunodeficiency virus: A case series. Clin Infect Dis. 71:2021–2022. 2020.PubMed/NCBI View Article : Google Scholar
12	Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC, Armstrong WS, et al: Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia. AIDS. 34(1789)2020.PubMed/NCBI View Article : Google Scholar
13	Joyner MJ, Bruno KA, Klassen SA, Kunze KL, Johnson PW, Lesser ER, Wiggins CC, Senefeld JW, Klompas AM, Hodge DO, et al: Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc. 95:1888–1897. 2020.PubMed/NCBI View Article : Google Scholar
14	Laracy J, Zucker J, Castor D, McMahon DJ, Guo TW, Yan M, Shalev N, Scherer M, Gordon P, Sobieszczyk M and Yin MT: HIV-1 infection does not change disease course or inflammatory pattern of SARS-CoV-2-infected patients presenting at a large urban medical center in New York City. Open Forum Infect Dis. 8(ofab029)2021.PubMed/NCBI View Article : Google Scholar
15	Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, et al: Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial. JAMA. 324:460–470. 2020.PubMed/NCBI View Article : Google Scholar
16	Patel VV, Felsen UR, Fisher M, Fazzari MJ, Ginsberg MS, Beil R, Akiyama MJ, Anastos K and Hanna DB: Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 86:224–230. 2021.PubMed/NCBI View Article : Google Scholar
17	Ridgway JP, Farley B, Benoit J-L, Frohne C, Hazra A, Pettit N, Pho M, Pursell K, Saltzman J, Schmitt J, et al: A case series of five people living with HIV hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDs. 34:331–335. 2020.PubMed/NCBI View Article : Google Scholar
18	Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ and Du P: Prevalence of HIV in patients hospitalized for COVID-19 and associated outcomes: A systematic review and meta-analysis. medRxiv: Jul 6, 2020 (Epub ahead of print). doi: doi.org/10.1101/2020.07.03.20143628.
19	Stoeckle K, Johnston CD, Jannat-Khah DP, Williams SC, Ellman TM, Vogler MA, Gulick RM, Glesby MJ and Choi JJ: COVID-19 in hospitalized adults with HIV. Open Forum Infect Dis. 7(ofaa327)2020.PubMed/NCBI View Article : Google Scholar
20	Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F and Casado JL: COVID-19 ID Team. Description of COVID-19 in HIV-infected individuals: A single-centre, prospective cohort. Lancet HIV. 7:e554–e64. 2020.PubMed/NCBI View Article : Google Scholar
21	Malekifar P, Pakzad R, Shahbahrami R, Zandi M, Jafarpour A, Rezayat SA, Akbarpour S, Shabestari AN, Pakzad I, Hesari E, et al: Viral coinfection among COVID-19 PATIENT groups: An update systematic review and meta-analysis. Biomed Res Int. 3(2021)2021.PubMed/NCBI View Article : Google Scholar
22	Health NIo: Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. NIH, Bethesda, MD, 2020.
23	Hosseini P, Afzali S, Karimi M, Zandi M, Zebardast A, Latifi T, Tabibzadeh A, Ramezani A, Zakeri A, Zakeri A, et al: The coronavirus disease 2019 and effect on liver function: A hidden and vital interaction beyond the respiratory system. Rev Med Microbiol. 33:e161–e179. 2022.
24	Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, et al: Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 69(458)2020.PubMed/NCBI View Article : Google Scholar
25	Soltani S, Zakeri A, Zandi M, Kesheh MM, Tabibzadeh A, Dastranj M, Faramarzi S, Didehdar M, Hafezi H, Hosseini P and Farahani A: The role of bacterial and fungal human respiratory microbiota in COVID-19 patients. Biomed Res Int. 2021(6670798)2021.PubMed/NCBI View Article : Google Scholar
26	Pakzad R, Malekifar P, Shateri Z, Zandi M, Akhavan Rezayat S, Soleymani M, Karimi MR, Ahmadi SE, Shahbahrami R, Pakzad I, et al: Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis. J Clin Lab Anal. 36(e24151)2022.PubMed/NCBI View Article : Google Scholar